| scholarly article | Q13442814 |
| P50 | author | Thomas A Einhorn | Q37368119 |
| Philip C. Trackman | Q40642250 | ||
| P2093 | author name string | Michael Song | |
| Louis C Gerstenfeld | |||
| Nathan A Wigner | |||
| Elise F Morgan | |||
| Sanjeev Kakar | |||
| Maisa O Al-Sebaei | |||
| George L Barnes | |||
| Daniel Toben | |||
| Kimberly A Jacobsen | |||
| Lincoln J Miara | |||
| Siddharth Vora | |||
| Gregory Hon | |||
| P2860 | cites work | Parathyroid hormone is essential for normal fetal bone formation | Q24551862 |
| P433 | issue | 12 | |
| P921 | main subject | bone fracture | Q68833 |
| cartilage development | Q5104524 | ||
| P304 | page(s) | 1903-1912 | |
| P577 | publication date | 2007-12-01 | |
| P1433 | published in | Journal of Bone and Mineral Research | Q15750941 |
| P1476 | title | Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures | |
| P478 | volume | 22 |
| Q37109477 | 2011 AOA Symposium: Tissue Engineering and Tissue Regeneration: AOA critical issues |
| Q36634998 | A PTH-responsive circadian clock operates in ex vivo mouse femur fracture healing site |
| Q37176129 | A perspective: engineering periosteum for structural bone graft healing. |
| Q90533734 | Adjuvant therapies for the enhancement of microfracture technique in cartilage repair |
| Q33859459 | Aging periosteal progenitor cells have reduced regenerative responsiveness to bone injury and to the anabolic actions of PTH 1-34 treatment |
| Q60933239 | Anabolic Therapies in Osteoporosis and Bone Regeneration |
| Q35078764 | Anabolic agents and bone quality |
| Q52600423 | Anabolic agents: what is beyond osteoporosis? |
| Q38017621 | Anti-osteoporosis therapy and fracture healing |
| Q51435874 | BMPR1A antagonist differentially affects cartilage and bone formation during fracture healing. |
| Q37193616 | Beta-catenin in the race to fracture repair: in it to Wnt. |
| Q28076668 | Bone healing in 2016 |
| Q35593289 | Bone healing: little secrets |
| Q43038767 | Calcitonin gene-related peptide (CGRP) inhibits apoptosis in human osteoblasts by β-catenin stabilization. |
| Q64089381 | Can Three Months of Teriparatide Be One of Treatment Options for Osteoporotic Vertebral Compression Fracture Patients? |
| Q33965633 | Can an anti-fracture agent heal fractures? |
| Q37886780 | Choosing a treatment for patients at the time a fracture is presented |
| Q36762372 | Conjugated linoleic acid and calcium co-supplementation improves bone health in ovariectomised mice |
| Q58765386 | Continuous infusion of PTH delayed fracture healing in mice |
| Q27025995 | Current insights on the regenerative potential of the periosteum: molecular, cellular, and endogenous engineering approaches |
| Q90450541 | Effect of Osteoporosis Medication on Fracture Healing: An Evidence Based Review |
| Q38595303 | Effect of osteoporosis medications on fracture healing |
| Q92030293 | Effects of Intermittent Administration of Parathyroid Hormone and Parathyroid Hormone-Related Protein on Fracture Healing: A Narrative Review of Animal and Human Studies |
| Q92136327 | Effects of pentoxifylline and alendronate on fracture healing in ovariectomy-induced osteoporosis in rats |
| Q33988218 | Endogenous PTH deficiency impairs fracture healing and impedes the fracture-healing efficacy of exogenous PTH(1-34). |
| Q35916945 | Endogenous tissue engineering: PTH therapy for skeletal repair. |
| Q33767790 | Exogenous activation of Wnt/β-catenin signaling attenuates binge alcohol-induced deficient bone fracture healing |
| Q53085903 | Experimental stimulation of bone healing with teriparatide: histomorphometric and microhardness analysis in a mouse model of closed fracture. |
| Q47705225 | Formononetin, a methoxy isoflavone, enhances bone regeneration in a mouse model of cortical bone defect |
| Q37430434 | Fracture healing and drug therapies in osteoporosis. |
| Q33635563 | Fracture healing is accelerated in the absence of the adaptive immune system. |
| Q38981442 | Fracture healing physiology and the quest for therapies for delayed healing and nonunion |
| Q26851958 | Fracture healing: mechanisms and interventions |
| Q47816372 | Functional block of IL-17 cytokine promotes bone healing by augmenting FOXO1 and ATF4 activity in cortical bone defect model |
| Q39159014 | Functional role of Runx3 in the regulation of aggrecan expression during cartilage development |
| Q35730423 | Generation of closed transverse fractures in small animals. |
| Q54154094 | Healing efficacy of fracture-targeted GSK3β inhibitor-loaded micelles for improved fracture repair. |
| Q37997375 | Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper |
| Q89668129 | Inducible expression of Wnt7b promotes bone formation in aged mice and enhances fracture healing |
| Q35041009 | Inhibition of beta-catenin signaling by Pb leads to incomplete fracture healing |
| Q39180892 | Inhibition of the canonical Wnt pathway by high glucose can be reversed by parathyroid hormone-related protein in osteoblastic cells |
| Q36127944 | Intermittent Administration of Parathyroid Hormone [1-34] Prevents Particle-Induced Periprosthetic Osteolysis in a Rat Model |
| Q34294193 | Intermittent PTHrP(1-34) exposure augments chondrogenesis and reduces hypertrophy of mesenchymal stromal cells |
| Q43463995 | Intermittent parathyroid hormone administration improves periodontal healing in rats. |
| Q31051550 | Locally administrated perindopril improves healing in an ovariectomized rat tibial osteotomy model |
| Q36873339 | Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteoporosis |
| Q46374125 | Loss of Gi G-Protein-Coupled Receptor Signaling in Osteoblasts Accelerates Bone Fracture Healing. |
| Q37230323 | Management of glucocorticoids-induced osteoporosis: role of teriparatide |
| Q36953988 | Measurement of fracture callus material properties via nanoindentation |
| Q35866382 | Medicarpin, a Natural Pterocarpan, Heals Cortical Bone Defect by Activation of Notch and Wnt Canonical Signaling Pathways |
| Q27023598 | Mesenchymal Stem Cells in Bone Regeneration |
| Q33384778 | Micro-computed tomography assessment of fracture healing: relationships among callus structure, composition, and mechanical function. |
| Q53826381 | Optimal administration frequency and dose of teriparatide for acceleration of biomechanical healing of long-bone fracture in a mouse model. |
| Q89359657 | Origin of Reparative Stem Cells in Fracture Healing |
| Q37738183 | Orthopedic uses of teriparatide |
| Q38183792 | Overview of skeletal repair (fracture healing and its assessment). |
| Q47144970 | PTH 1-34 Ameliorates the Osteopenia and Delayed Healing of Stabilized Tibia Fracture in Mice with Achondroplasia Resulting from Gain-Of-Function Mutation of FGFR3. |
| Q91843619 | PTH1-34 improves bone healing by promoting angiogenesis and facilitating MSCs migration and differentiation in a stabilized fracture mouse model |
| Q34560011 | Parathyroid hormone 1-34 enhances extracellular matrix deposition and organization during flexor tendon repair. |
| Q36044304 | Parathyroid hormone resets the cartilage circadian clock of the organ-cultured murine femur |
| Q34142098 | Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis |
| Q33729548 | Pharmacological management of osteogenesis |
| Q36808466 | Prostaglandin-mediated inhibition of PTH-stimulated β-catenin signaling in osteoblasts by bone marrow macrophages |
| Q36517297 | Robust Circadian Rhythm and Parathyroid Hormone-Induced Resetting during Hypertrophic Differentiation in ATDC5 Chondroprogenitor Cells |
| Q37989404 | Role of FGFs/FGFRs in skeletal development and bone regeneration |
| Q35134403 | Role of Wnt signaling in fracture healing |
| Q36020434 | Role of fibroblast growth factor 2 and Wnt signaling in anabolic effects of parathyroid hormone on bone formation |
| Q34994584 | Runx1 is critical for PTH-induced onset of mesenchymal progenitor cell chondrogenic differentiation |
| Q34016769 | Runx2 is required for early stages of endochondral bone formation but delays final stages of bone repair in Axin2-deficient mice. |
| Q37374315 | Secreted frizzled related protein 1 is a target to improve fracture healing |
| Q95275775 | Short-Term Teriparatide for Bone Marrow Edema Secondary to Complex Regional Pain Syndrome: Case Reports on Efficacy After Two Years of Follow-Up |
| Q35357373 | Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice |
| Q43231238 | Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats |
| Q35124201 | Systemic treatment with telmisartan improves femur fracture healing in mice |
| Q51228185 | Systemic treatment with the sphingosine-1-phosphate analog FTY720 does not improve fracture healing in mice. |
| Q50167168 | Teriparatide (human PTH1-34) compensates for impaired fracture healing in COX-2 deficient mice. |
| Q35967736 | Teriparatide - Indications beyond osteoporosis |
| Q35165694 | Teriparatide Therapy as an Adjuvant for Tissue Engineering and Integration of Biomaterials |
| Q35525309 | Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis. |
| Q34530298 | Teriparatide therapy and beta-tricalcium phosphate enhance scaffold reconstruction of mouse femoral defects |
| Q34544242 | Teriparatide therapy enhances devitalized femoral allograft osseointegration and biomechanics in a murine model |
| Q27010303 | The Effect of Teriparatide on Fracture Healing of Osteoporotic Patients: A Meta-Analysis of Randomized Controlled Trials |
| Q46960679 | The Influence of Orthotopic Paraspinal Muscle-Pediculated Bone Flaps on Posterior Spinal Fusion in a Canine Model |
| Q28512113 | The Wnt serpentine receptor Frizzled-9 regulates new bone formation in fracture healing |
| Q37263387 | The cell biology of parathyroid hormone in osteoblasts |
| Q91910260 | The combination of microfracture with induction of Wnt / β- Catenin pathway, leads to enhanced cartilage regeneration |
| Q34667582 | The effect of PTH(1-34) on fracture healing during different loading conditions |
| Q38264342 | The effect of parathyroid hormone and teriparatide on fracture healing |
| Q86933226 | The effect of teriparatide to alleviate pain and to prevent vertebral collapse after fresh osteoporotic vertebral fracture |
| Q49819860 | The effect of teriparatide treatment on circulating periostin and its relationship to regulators of bone formation and BMD in postmenopausal women with osteoporosis. |
| Q37255748 | The role of Wnt proteins in arthritis |
| Q39356695 | The roles of signaling pathways in bone repair and regeneration |
| Q33438889 | Transcriptional analysis of fracture healing and the induction of embryonic stem cell-related genes |
| Q47099477 | Triweekly administration of parathyroid hormone (1-34) accelerates bone healing in a rat refractory fracture model. |
| Q35605991 | Wnt signaling and orthopedics, an overview |
| Q37561706 | Wnt signaling during fracture repair |
| Q51567338 | Yeast-incorporated gallium promotes fracture healing by increasing callus bony area and improving trabecular microstructure on ovariectomized osteopenic rats. |
| Q84717324 | [Osteoblasts : cellular and molecular regulatory mechanisms in fracture healing] |
Search more.